Investor relations pageIR page | no data available |
Founding year | no data available |
Headquarter | , , no data available |
Employees | 335 (as per Q2 2017)no data available |
Sector | Medical Devices, HealthcareMedical Devices, Healthcareno data available |
Ticker | TCMDno data available |
Financial year endsFY ends | End of Decemberno data available |
Last Closing Price as per , in USD |
n/a |
Market Capitalisation in million USD |
0n/a |
Enterprise Value in million USD |
0n/a |
Common Shares Outstanding as per Jun 30, 2017 |
17,541,371n/a |
Preferred Shares Outstanding as per Jun 30, 2017 |
17,526,171n/a |
Average Basic Shares Outstanding TTM |
15,752,224n/a |
Average Diluted Shares Outstanding TTM |
18,080,481n/a |
Index Membership |
n/a
|
Revenues | 97n/a |
Gross Profit | 71n/a |
Operating Income | 2n/a |
EBITDA | 3n/a |
Net Profit | 5n/a |
Cash and Cash Equivalents | 39n/a |
Receivables | 13n/a |
Total Current Assets | 67n/a |
PP&E | 3n/a |
Total Assets | 78n/a |
Accounts Payable | 7n/a |
Current Debt | 0n/a |
Total Current Liabilities | 11n/a |
Long-Term Debt | 0n/a |
Total Liabilities | 12n/a |
Total Equity | 66n/a |
Depreciation & Amortisation | 1n/a |
Change in Working Capital | -6n/a |
Operating Cash Flow | 3n/a |
Net Change in PP&E and Intangibles | -2n/a |
Investing Cash Flow | -23n/a |
Dividends Paid | -8n/a |
Financing Cash Flow | 31n/a |
Total Change in Cash | 11n/a |
Free Cash Flow | -2n/a |
Gross Margin | 72.8%n/a |
Operating Margin | 2.1%n/a |
Net Profit Margin | 5.3%n/a |
Return on Equity | 7.8%n/a |
Return on Assets | 6.6%n/a |
Basic EPS | 0.33n/a |
Diluted EPS | 0.29n/a |
Sales per Share | 6.17n/a |
Book Value per Share | 4.20n/a |
FCF per Share | -0.13n/a |
Dividends per Share | 0.52n/a |
Price to Earnings Ratio | n/a |
Price to Sales Ratio | n/a |
Price to Book Value | n/a |
Price to Free Cash Flow | n/a |
EV/EBITDA | n/a |
EV/Sales | n/a |
Book to Market Value | n/a |
Current Ratio | 602.2%n/a |
Liabilities to Equity Ratio | 17.7%n/a |
Debt to Assets Ratio | 0.0%n/a |
in million USD | FY '14 | FY '15 | FY '16 |
---|---|---|---|
|
48
|
63
|
85
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
-13
|
-17
|
-23
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
35
|
46
|
62
|
|
0
|
0
|
0
|
|
-31
|
-43
|
-57
|
|
-28
|
-38
|
-53
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
-3
|
-4
|
-4
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
4
|
3
|
4
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
4
|
3
|
4
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
4
|
3
|
4
|
|
-2
|
-2
|
-1
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
2
|
1
|
3
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
2
|
1
|
3
|
|
0
|
0
|
0
|
|
2
|
1
|
3
|
|
-2
|
-2
|
-1
|
|
0
|
0
|
0
|
|
0
|
0
|
2
|
Remarks |
restated on Feb 27, 2017
n/a
calculated values,
|
restated on Feb 27, 2017
n/a
calculated values,
|
restated on Feb 27, 2017
n/a
calculated values,
|
in million USD | FY '14 | FY '15 | FY '16 |
---|---|---|---|
Assets | |||
|
n/a
|
7
|
42
|
|
n/a
|
7
|
31
|
|
n/a
|
0
|
11
|
|
n/a
|
14
|
15
|
|
n/a
|
14
|
15
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
6
|
7
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
2
|
1
|
|
n/a
|
1
|
1
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
2
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
29
|
64
|
|
n/a
|
1
|
2
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
6
|
8
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
3
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
0
|
0
|
|
n/a
|
6
|
5
|
|
n/a
|
8
|
10
|
|
n/a
|
37
|
74
|
Liabilities and owners' equity | |||
|
n/a
|
9
8511000
|
14
13726000
|
|
n/a
|
3
3336000
|
5
5018000
|
|
n/a
|
1
904000
|
1
823000
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
4
4271000
|
8
7885000
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
1
991000
|
0
67000
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
1
991000
|
0
67000
|
|
n/a
|
10
9502000
|
14
13793000
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
193000
|
1
503000
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
193000
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
1
503000
|
|
n/a
|
0
193000
|
1
503000
|
|
n/a
|
10
9695000
|
14
14296000
|
|
n/a
|
33
32927000
|
0
0
|
|
n/a
|
0
3000
|
62
62423000
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
-6
-5652000
|
-3
-2773000
|
|
n/a
|
0
0
|
0
-11000
|
|
n/a
|
27
27278000
|
60
59639000
|
|
n/a
|
0
0
|
0
0
|
|
n/a
|
27
27278000
|
60
59639000
|
|
n/a
|
37
36973000
|
74
73935000
|
Remarks | restated on n/a | restated on Feb 27, 2017 n/a | restated on Aug 7, 2017 n/a |
in million USD | FY '14 | FY '15 | FY '16 |
---|---|---|---|
|
2
|
1
|
3
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
1
|
1
|
1
|
|
2
|
1
|
2
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
-6
|
-1
|
2
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
-1
|
2
|
7
|
|
0
|
-1
|
-1
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
-11
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
-1
|
-12
|
|
0
|
0
|
-8
|
|
0
|
-1
|
-5
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
1
|
41
|
|
0
|
1
|
41
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
0
|
|
0
|
0
|
28
|
|
-1
|
2
|
24
|
|
0
|
0
|
0
|
|
-1
|
2
|
24
|
|
0
|
0
|
0
|
|
-1
|
2
|
24
|
Remarks |
restated on Feb 27, 2017
n/a
calculated values,
|
restated on Feb 27, 2017
n/a
calculated values,
|
restated on Feb 27, 2017
n/a
calculated values,
|